Biotalys BTLS

BRU: BTLS | ISIN: BE0974386188   25/04/2024
3,050 EUR (0,00%)
(0,00%)   25/04/2024

23 april 2024 · Results of the Ordinary and Extraordinary Shareholders’ Meeting · Persbericht

29 maart 2024 · Results of the Special Shareholders’ Meeting · Persbericht

20 maart 2024 · Invitation to the ordinary general shareholders meeting and an extraordinary shareholders meeting · Persbericht

18 maart 2024 · Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG · Persbericht

26 februari 2024 · Invitation to a Special Shareholders’ Meeting · Persbericht

22 februari 2024 · Biotalys Reports Full-Year 2023 Financial Results and Business Highlights · Persbericht

8 februari 2024 · Biotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S. · Persbericht

31 januari 2024 · Information on the total number of voting rights and shares · Persbericht

22 januari 2024 · Biotalys Notice of Full Year 2023 Results and Business Highlights · Persbericht

19 december 2023 · Biotalys Announces Results of Independent Field Trials in the U.S. · Persbericht

29 november 2023 · Biotalys Provides Company Update · Persbericht

5 oktober 2023 · Kevin Helash commences role as Chief Executive Officer of Biotalys · Persbericht

2 oktober 2023 · Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase · Persbericht

26 september 2023 · Biotalys announces participation at upcoming scientific, industry and investor events · Persbericht

23 augustus 2023 · Biotalys Reports Half-Year 2023 Financial Results and Business Highlights · Persbericht

20 juli 2023 · Invitation to a Special Shareholders’ Meeting · Persbericht

5 juli 2023 · Publication of transparency notification · Persbericht

12 juni 2023 · Biotalys announces closing of private placement · Persbericht

7 juni 2023 · Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million · Persbericht

31 mei 2023 · Biotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field Trials · Persbericht

Mijn selecties